Latest Breaking News On - Asia healthcare holdings - Page 1 : vimarsana.com

VC investor HealthQuad exits speciality hospital chain AINU with 4X return

Data Vantage: Asia Healthcare, ANEXT & GreenArc Capital in focus

Private equity firm TPG Capital and Singapore wealth fund GIC have topped up their investments in Asia Healthcare Holdings (AHH).

Medtech: How India can lower its huge import dependence

India Business News: Many wonder why healthcare in India is so expensive.

TPG, Singapore sovereign fund GIC to top up India exposure for bolt-on deal

Private equity firm TPG and Singapore’s sovereign wealth fund GIC, which were among the most active large institutional investors in India last year, are in ......

AINU completes 1,000 robotic surgeries

Asian Institute of Nephrology and Urology (AINU), India's largest single specialty hospital network of urology and nephrology care, on Tuesday announced that it has completed 1,000 robotic surgeries.The robotic surgeries were successfully ...

NephroPlus sale: Quadria in talks to buy into dialysis chain NephroPlus

Quadria Capital, an Asia-focused private equity fund, is in talks to acquire a significant minority stake in India's largest dialysis chain, NephroPlus, valued at ₹2,000 crore ($250 million). Existing investors, Bessemer Venture Partners and International Finance Corporation, will exit by selling a 30% stake together, while Investcorp is likely to sell a small stake. NephroPlus, founded in 2009, operates 300+ dialysis centres in over 180 cities across four countries.

Hospitals: Hospitals see 15x surge in Private equity-Venture capital funds in 4 years

India Business News: Investor interest in hospitals peaked this year with investments by private equity (PE) and venture capital (VC) firms rising by over 15 times to cros

Mint Healthcare Summit: Specialty Hospital Chains Can Bridge Demand-Supply Gap, Says AHH's Vishal Bali

Pharma and healthcare sectors thrive despite dip in deal volume in Q3CY23

Bhanu Prakash Kalmath, Partner and Healthcare Sector Leader, Grant Thornton Bharat, says the sector’s growth drivers such as increasing demand, tech adoption, and government support, likely to persist

Pharma and healthcare sector continue to attract investment despite volume dip in Q3 2023